INFLIXIMAB-DYYB for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 212 adverse event reports in the FDA FAERS database where INFLIXIMAB-DYYB was used for Psoriasis.
Most Reported Side Effects for INFLIXIMAB-DYYB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 14,256 | 55.7% | 274 | 3,718 |
| Condition aggravated | 10,275 | 40.2% | 163 | 3,133 |
| Intentional product use issue | 7,549 | 29.5% | 125 | 1,938 |
| Inappropriate schedule of product administration | 5,977 | 23.4% | 101 | 1,740 |
| Arthralgia | 4,615 | 18.0% | 74 | 1,334 |
| Drug ineffective | 3,112 | 12.2% | 27 | 854 |
| Fatigue | 3,111 | 12.2% | 55 | 900 |
| Weight increased | 2,848 | 11.1% | 61 | 822 |
| Malaise | 2,766 | 10.8% | 74 | 1,002 |
| Weight decreased | 2,703 | 10.6% | 66 | 926 |
| Blood pressure increased | 2,309 | 9.0% | 42 | 682 |
| Covid-19 | 2,262 | 8.8% | 42 | 653 |
| Headache | 2,216 | 8.7% | 25 | 639 |
| Nausea | 2,158 | 8.4% | 22 | 766 |
| Pain | 2,089 | 8.2% | 30 | 713 |
Other Indications for INFLIXIMAB-DYYB
Crohn's disease (10,657)
Colitis ulcerative (6,767)
Product used for unknown indication (2,311)
Rheumatoid arthritis (2,153)
Ankylosing spondylitis (1,529)
Psoriatic arthropathy (1,044)
Hidradenitis (189)
Sarcoidosis (188)
Colitis (150)
Inflammatory bowel disease (106)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)